National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meeting, 43534 [2010-18203]
Download as PDF
<![CDATA[
43534
Federal Register / Vol. 75, No. 142 / Monday, July 26, 2010 / Notices
During this meeting, the Committee will
discuss the currently available evidence
regarding the clinical benefits and
harms of on-label and off-label use of
bone morphogenetic proteins.
Background information about this
topic, including panel materials, is
available at https://www.cms.hhs.gov/
center/coverage.asp. We encourage the
participation of appropriate
organizations with expertise in the use
of bone morphogenetic protein.
jlentini on DSKJ8SOYB1PROD with NOTICES
II. Meeting Format
This meeting is open to the public.
The Committee will hear oral
presentations from the public for
approximately 45 minutes. The
Committee may limit the number and
duration of oral presentations to the
time available. Your comments should
focus on issues specific to the list of
topics that we have proposed to the
Committee. The list of research topics to
be discussed at the meeting will be
available on the following Web site
prior to the meeting: https://
www.cms.hhs.gov/mcd/index_list
.asp?list_type=mcac. We require that
you declare at the meeting whether you
have any financial involvement with
manufacturers (or their competitors) of
any items or services being discussed.
The Committee will deliberate openly
on the topics under consideration.
Interested persons may observe the
deliberations, but the Committee will
not hear further comments during this
time except at the request of the
chairperson. The Committee will also
allow a 15-minute unscheduled open
public session for any attendee to
address issues specific to the topics
under consideration. At the conclusion
of the day, the members will vote and
the Committee will make its
recommendation(s) to CMS.
III. Registration Instructions
CMS’ Coverage and Analysis Group is
coordinating meeting registration. While
there is no registration fee, individuals
must register to attend. You may register
online at https://www.cms.gov/apps/
events/event.asp?id=602&Kw=
&Mh=NoMonth&cboOrder=date&Yr=
NoYear&type=2, via e-mail at
MEDCAC_Registration@cms.hhs.gov, or
by phone by contacting the person listed
in the FOR FURTHER INFORMATION
CONTACT section of this notice by the
deadline listed in the DATES section of
this notice. Please provide your full
name (as it appears on your state-issued
driver’s license), address, organization,
telephone, fax number(s), and e-mail
address. You will receive a registration
confirmation with instructions for your
arrival at the CMS complex or you will
VerDate Mar<15>2010
16:04 Jul 23, 2010
Jkt 220001
be notified the seating capacity has been
reached. You must register for the
Webinar portion of the meeting at
https://webinar.cms.hhs.gov/bmp/event/
registration.html?preview=false by the
deadline listed in the DATES section of
this notice.
IV. Security, Building, and Parking
Guidelines
This meeting will be held in a Federal
government building; therefore, Federal
security measures are applicable. We
recommend that confirmed registrants
arrive reasonably early, but no earlier
than 45 minutes prior to the start of the
meeting, to allow additional time to
clear security. Security measures
include the following:
• Presentation of government-issued
photographic identification to the
Federal Protective Service or Guard
Service personnel.
• Inspection of vehicle’s interior and
exterior (this includes engine and trunk
inspection) at the entrance to the
grounds. Parking permits and
instructions will be issued after the
vehicle inspection.
• Inspection, via metal detector or
other applicable means of all persons
brought entering the building. We note
that all items brought into CMS,
whether personal or for the purpose of
presentation or to support a
presentation, are subject to inspection.
We cannot assume responsibility for
coordinating the receipt, transfer,
transport, storage, set-up, safety, or
timely arrival of any personal
belongings or items used for
presentation or to support a
presentation.
Note: Individuals who are not registered in
advance will not be permitted to enter the
building and will be unable to attend the
meeting. The public may not enter the
building earlier than 45 minutes prior to the
convening of the meeting. All visitors must
be escorted in areas other than the lower and
first floor levels in the Central Building.
Authority: 5 U.S.C. App. 2, section 10(a).
(Catalog of Federal Domestic Assistance
Program No. 93.773, Medicare—Hospital
Insurance; and Program No. 93.774,
Medicare—Supplementary Medical
Insurance Program)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism; Initial
Review Group Biomedical Research Review
Subcommittee.
Date: October 18–19, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Philippe Marmillot, PhD,
Scientific Review Officer, National Institutes
of Health, National Institute on Alcohol
Abuse and Alcoholism, 5635 Fishers Lane,
Room 2019, Bethesda, MD 20892, 301–443–
2861, marmillotp@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271. Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants;
93,701, ARRA Related Biomedical Research
and Research Support Awards, National
Institutes of Health, HHS)
Dated: July 14, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–18203 Filed 7–23–10; 8:45 am]
BILLING CODE 4140–01–P
Dated: July 15, 2010.
Barry M. Straube,
Chief Medical Officer and Director, Office
of Clinical Standards and Quality, Centers
for Medicare & Medicaid Services.
[FR Doc. 2010–18209 Filed 7–23–10; 8:45 am]
BILLING CODE 4120–01–P
PO 00000
Frm 00050
Fmt 4703
Sfmt 9990
E:\FR\FM\26JYN1.SGM
26JYN1
]]>Agencies
[Federal Register Volume 75, Number 142 (Monday, July 26, 2010)]
[Notices]
[Page 43534]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-18203]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse and Alcoholism; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable materials, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Alcohol Abuse and
Alcoholism; Initial Review Group Biomedical Research Review
Subcommittee.
Date: October 18-19, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Philippe Marmillot, PhD, Scientific Review
Officer, National Institutes of Health, National Institute on
Alcohol Abuse and Alcoholism, 5635 Fishers Lane, Room 2019,
Bethesda, MD 20892, 301-443-2861, marmillotp@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.271.
Alcohol Research Career Development Awards for Scientists and
Clinicians; 93.272, Alcohol National Research Service Awards for
Research Training; 93.273, Alcohol Research Programs; 93.891,
Alcohol Research Center Grants; 93,701, ARRA Related Biomedical
Research and Research Support Awards, National Institutes of Health,
HHS)
Dated: July 14, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-18203 Filed 7-23-10; 8:45 am]
BILLING CODE 4140-01-P
